UBS Group’s Repligen RGEN Stock Holding History

UBS Group’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-11,900	Closed	-$2.14M	–	9903
2023 Q4	$2.14M	Sell	11,900 -600	-5%	-$93.4K	﹤0.01%	3750
2023 Q3	$1.99M	Sell	12,500 -2,500	-17%	-$409K	﹤0.01%	3439
2023 Q2	$2.12M	Buy	15,000 +5,000	+50%	+$802K	﹤0.01%	3465
2023 Q1	$1.68M	Buy	+10,000	New	+$1.78M	﹤0.01%	3607
2022 Q2	–	Sell	-2,000	Closed	-$376K	–	10829
2022 Q1	$376K	Buy	+2,000	New	+$380K	﹤0.01%	4899
2020 Q4	–	Sell	-18,000	Closed	-$2.66M	–	8685
2020 Q3	$2.66M	Buy	+18,000	New	+$2.57M	﹤0.01%	2778
2016 Q3	–	Sell	-40,000	Closed	-$1.09M	–	7888
2016 Q2	$1.09M	Buy	+40,000	New	+$1.02M	﹤0.01%	3312
2015 Q4	–	Sell	-85,000	Closed	-$2.37M	–	8530
2015 Q3	$2.37M	Buy	+85,000	New	+$3.07M	﹤0.01%	2583
2015 Q1	–	Sell	-2,100	Closed	-$42K	–	9269
2014 Q4	$42K	Buy	+2,100	New	+$47K	﹤0.01%	6703

Other funds holding RGEN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

UCFA

United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

UBS Group's RGEN Position: Q1 2026 in Review

UBS Group increased its Repligen (RGEN) stake by 92% in Q1 2026, buying an estimated $45M and bringing the position to 670,329 shares worth $79M. The position accounts for 0.01% of the portfolio, ranked #1226.

UBS Group first reported a position in RGEN in Q4 2014 and has held it in 46 quarters since. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

UBS Group held 670,329 shares of Repligen worth $79M as of Q1 2026.
UBS Group bought 321,941 Repligen shares in Q1 2026, an estimated $45M.
Repligen made up 0.01% of UBS Group's portfolio in Q1 2026, its #1226 holding.
UBS Group first reported a position in Repligen in Q4 2014 and has held it in 46 quarters since.
441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.